1. Home
  2. ACRV vs GASS Comparison

ACRV vs GASS Comparison

Compare ACRV & GASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • GASS
  • Stock Information
  • Founded
  • ACRV 2018
  • GASS 2004
  • Country
  • ACRV United States
  • GASS Greece
  • Employees
  • ACRV N/A
  • GASS N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • GASS Marine Transportation
  • Sector
  • ACRV Health Care
  • GASS Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • GASS Nasdaq
  • Market Cap
  • ACRV 247.8M
  • GASS 211.6M
  • IPO Year
  • ACRV 2022
  • GASS 2005
  • Fundamental
  • Price
  • ACRV $8.04
  • GASS $5.97
  • Analyst Decision
  • ACRV Strong Buy
  • GASS
  • Analyst Count
  • ACRV 5
  • GASS 0
  • Target Price
  • ACRV $22.40
  • GASS N/A
  • AVG Volume (30 Days)
  • ACRV 44.7K
  • GASS 138.7K
  • Earning Date
  • ACRV 11-13-2024
  • GASS 11-26-2024
  • Dividend Yield
  • ACRV N/A
  • GASS N/A
  • EPS Growth
  • ACRV N/A
  • GASS 68.82
  • EPS
  • ACRV N/A
  • GASS 1.84
  • Revenue
  • ACRV N/A
  • GASS $152,143,156.00
  • Revenue This Year
  • ACRV N/A
  • GASS $16.26
  • Revenue Next Year
  • ACRV N/A
  • GASS N/A
  • P/E Ratio
  • ACRV N/A
  • GASS $3.26
  • Revenue Growth
  • ACRV N/A
  • GASS N/A
  • 52 Week Low
  • ACRV $3.19
  • GASS $5.33
  • 52 Week High
  • ACRV $11.90
  • GASS $8.84
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 48.60
  • GASS 45.86
  • Support Level
  • ACRV $7.69
  • GASS $5.59
  • Resistance Level
  • ACRV $8.54
  • GASS $6.13
  • Average True Range (ATR)
  • ACRV 0.34
  • GASS 0.17
  • MACD
  • ACRV -0.03
  • GASS 0.04
  • Stochastic Oscillator
  • ACRV 23.59
  • GASS 77.78

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

Share on Social Networks: